Kewaunee Scientific Q1 FY2025 sales down 2.9%, EPS $0.74 vs $0.86, backlog up 13%

KEWAUNEE SCIENTIFIC CORP /DE/

2025-Q1 EPS reported $0.74 revenue$48,393,000

Sales $48.4M, down 2.9% YoY; diluted EPS $0.74 vs $0.86 in prior year quarter.
Domestic net earnings rose to $2.9M from $2.7M; International sales fell 10.7% due to India site delays.
Order backlog grew to $159.4M from $140.8M a year ago (+13%).
Adjusted EBITDA (excl. professional fees) $4.1M; professional fees unrelated to core business increased.
Management sees strong backlog and quoting activity for another strong year.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.